XML 37 R26.htm IDEA: XBRL DOCUMENT v3.21.2
Shareholders' Equity (Tables)
 6 Months Ended
Jul. 04, 2021
Equity [Abstract]  
(Loss) / Earnings per share The following table sets forth the computation of basic and diluted (loss)/earnings per share:
Three Months EndedSix Months Ended
July 4, 2021June 28, 2020July 4, 2021June 28, 2020
Numerator:
Net (loss)/income attributable to Sonoco$(334,070)$55,211 $(261,774)$135,656 
Denominator:
Weighted average common shares outstanding:
Basic100,082 100,971 100,571 100,915 
Dilutive effect of stock-based compensation— 138 — 194 
Diluted100,082 101,109 100,571 101,109 
Net (loss)/income attributable to Sonoco per common share:
Basic$(3.34)$0.55 $(2.60)$1.34 
Diluted$(3.34)$0.55 $(2.60)$1.34 
Cash dividends$0.45 $0.43 $0.90 $0.86 
Schedule of antidilutive securities excluded from computation of earnings per share The average numbers of SARs that were anti-dilutive and, therefore, not included in the computation of diluted earnings per share during the three- and six-month periods ended July 4, 2021 and June 28, 2020 were as follows:
Three Months EndedSix Months Ended
July 4, 2021June 28, 2020July 4, 2021June 28, 2020
Anti-dilutive stock appreciation rights— 1,191 214 890 
The following table sets forth the potentially dilutive securities excluded from the computation of diluted net loss per share during the three- and six-month periods ended July 4, 2021:
Three Months EndedSix Months Ended
July 4, 2021July 4, 2021
Dilutive securities excluded due to reported loss486 469